{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:56:57Z","timestamp":1790373417287,"version":"4.1.0"},"reference-count":99,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T00:00:00Z","timestamp":1419984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["openrespiratorymedicinejournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TORMJ"],"published-print":{"date-parts":[[2014,12,31]]},"abstract":"<jats:p>Bronchial asthma (BA) and Allergic rhinitis (AR) are common clinical problems encountered in day to day practice, where inhalational corticosteroids (ICS) or intranasal steroids (INS) are the mainstay of treatment. Iatrogenic Cushing syndrome (CS) is a well known complication of systemic steroid administration. ICS \/INS were earlier thought to be safe, but now more and more number of case reports of Iatrogenic Cushing syndrome have been reported, especially in those who are taking cytochrome P450 (CYP 450) inhibitors. Comparing to the classical clinical features of spontaneous Cushing syndrome, iatrogenic Cushing syndrome is more commonly associated with osteoporosis, increase in intra-ocular pressure, benign intracranial hypertension, aseptic necrosis of femoral head and pancreatitis, where as hypertension, hirsuitisum and menstrual irregularities are less common. Endocrine work up shows low serum cortisol level with evidence of HPA (hypothalamo-pituitary-adrenal) axis suppression. In all patients with features of Cushing syndrome with evidence of adrenal suppression always suspect iatrogenic CS. Since concomitant administration of cytochrome P450 inhibitors in patients on ICS\/INS can precipitate iatrogenic CS, avoidance of CYP450 inhibitors, its dose reduction or substitution of ICS are the available options. Along with those, measures to prevent the precipitation of adrenal crisis has to be taken. An update on ICS-\/INS- associated iatrogenic CS and its management is presented here.<\/jats:p>","DOI":"10.2174\/1874306401408010074","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T11:36:09Z","timestamp":1422012969000},"page":"74-84","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inhalational Steroids and Iatrogenic Cushing\u2019s Syndrome"],"prefix":"10.2174","volume":"8","author":[{"given":"Raveendran","family":"A.V","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1365-2222.2009.03321.x","volume":"39","author":"Hargreave FE","year":"2009","unstructured":"Hargreave FE, Nair P. \n                    The definition and diagnosis of asthma. \n                    Clin Exp Allergy  \n                    2009; \n                    39\n                    : 1652-8.","journal-title":"Clin Exp Allergy."},{"key":"refR2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2222.2005.02292.x","volume":"35","author":"Barnes PJ","year":"2005","unstructured":"Barnes PJ. \n                    Will it be steroids forever\u03ba. \n                    Clin Exp Allergy  \n                    2005; \n                    35\n                    : 843-5.","journal-title":"Clin Exp Allergy."},{"key":"refR3","unstructured":"Global strategy for asthma management and prevention NHLBI\/WHO workshop report March 1993 National Institutes of Health 2002. In: \n                    Publication number 95-36-59 issued January. \n                     1995."},{"key":"refR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1345\/aph.1L546","volume":"43","author":"Kelly HW","year":"2009","unstructured":"Kelly HW. \n                    Comparison of inhaled corticosteroids An update. \n                    Ann Pharmacother  \n                    2009; \n                    43\n                    : 519-27.","journal-title":"Ann Pharmacother."},{"key":"refR5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1164\/ajrccm.158.1.9707107","volume":"158","author":"Blais L","year":"1998","unstructured":"Blais L, Ernst P, Boivin JF , et al. \n                    Inhaled corticosteroids and the prevention of readmission to hospital for asthma. \n                    Am J Respir Crit Care Med  \n                    1998; \n                    158\n                    : 126-32.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM200008033430504","volume":"343","author":"Suissa S","year":"2000","unstructured":"Suissa S, Ernst P, Benayoun S , et al. \n                    Low-dose inhaled corticosteroids and the prevention of death from asthma. \n                    N Engl J Med  \n                    2000; \n                    343\n                    : 332-6.","journal-title":"N Engl J Med."},{"key":"refR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00012","volume":"139","author":"Barnes PJ","year":"2003","unstructured":"Barnes PJ, Adcock IM. \n                    How do corticosteroids work in asthma\u03ba. \n                    Ann Intern Med  \n                    2003; \n                    139\n                    : 359-70.","journal-title":"Ann Intern Med."},{"key":"refR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/pupt.2001.0312","volume":"15","author":"Umland SP","year":"2002","unstructured":"Umland SP, Schleimer RP, Johnston SL. \n                    Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. \n                    Pulm Pharmacol Ther  \n                    2002; \n                    15\n                    : 35-50.","journal-title":"Pulm Pharmacol Ther."},{"key":"refR9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1210\/me.2002-0106","volume":"16","author":"Yudt MR","year":"2002","unstructured":"Yudt MR, Cidlowski JA. \n                    The glucocorticoid receptor Coding a diversity of proteins and responses through a single gene. \n                    Mol Endocrinol  \n                    2002; \n                    16\n                    : 1719-26.","journal-title":"Mol Endocrinol."},{"key":"refR10","unstructured":"Global initiative for chronic obstructive lung disease (GOLD) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. \n                    Updated 2011 wwwgoldcopdcom Accessed 1 September \n                    2014."},{"key":"refR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","volume":"155","author":"Qaseem A","year":"2011","unstructured":"Qaseem A, Wilt TJ, Weinberger SE , et al. \n                    Diagnosis and management of stable chronic obstructive pulmonary disease A clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. \n                    Ann Intern Med  \n                    2011; \n                    155\n                    : 179-91.","journal-title":"Ann Intern Med."},{"key":"refR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1183\/09031936.00190908","volume":"34","author":"Suissa S","year":"2009","unstructured":"Suissa S, Barnes PJ. \n                    Inhaled corticosteroids in COPD The case against. \n                    Eur Respir J  \n                    2009; \n                    34\n                    : 13-6.","journal-title":"Eur Respir J."},{"key":"refR13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"Bafadhel M","year":"2011","unstructured":"Bafadhel M, McKenna S, Terry S , et al. \n                    Acute exacerbations of COPD Identification of biological clusters and their biomarkers. \n                    Am J Respir Crit Care Med  \n                    2011; \n                    184\n                    : 662-71.","journal-title":"Am J Respir Crit Care Med."},{"key":"refR14","first-page":"37","volume":"15","author":"Boezen HM","year":"2000","unstructured":"Boezen HM, Schouten JP, Weiss ST. \n                    The Dutch hypothesis on chronic nonspecific lung disease. \n                    Eur Respir Mon  \n                    2000; \n                    15\n                    : 37-47.","journal-title":"Eur Respir Mon."},{"key":"refR15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1513\/pats.200701-024FM","volume":"4","author":"Suissa S","year":"2007","unstructured":"Suissa S, McGhan R, Niewoehner D, Make B. \n                    Inhaled corticosteroids in chronic obstructive pulmonary disease. \n                    Proc Am Thorac Soc  \n                    2007; \n                    4\n                    : 535-42.","journal-title":"Proc Am Thorac Soc."},{"key":"refR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4104\/pcrj.2012.00092","volume":"22","author":"Price D","year":"2013","unstructured":"Price D, Yawn B, Brusselle G, Rossi A. \n                    Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. \n                    Prim Care Respir J  \n                    2013; \n                    22\n                    : 92-100.","journal-title":"Prim Care Respir J."},{"key":"refR17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","volume":"159","author":"Lipworth BJ","year":"1999","unstructured":"Lipworth BJ. \n                    Systemic adverse effects of inhaled corticosteroid therapy A systematic review and meta-analysis. \n                    Arch Intern Med  \n                    1999; \n                    159\n                    : 941-55.","journal-title":"Arch Intern Med."},{"key":"refR18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/rccm.200611-1630OC","volume":"176","author":"Ernst P","year":"2007","unstructured":"Ernst P, Gonzalez AV, Brassard P, Suissa S. \n                    Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. \n                    Am J Respir Crit Care Med  \n                    2007; \n                    176\n                    : 162-6.","journal-title":"Am J Respir Crit Care Med."},{"key":"refR19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.clinthera.2008.08.004","volume":"30","author":"Sobieraj DM","year":"2008","unstructured":"Sobieraj DM, White CM, Coleman CI. \n                    Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease A meta-analysis. \n                    Clin Ther  \n                    2008; \n                    30\n                    : 1416-25.","journal-title":"Clin Ther."},{"key":"refR20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","volume":"183","author":"Brassard P","year":"2011","unstructured":"Brassard P, Suissa S, Kezouh A, Ernst P. \n                    Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. \n                    Am J Respir Crit Care Med  \n                    2011; \n                    183\n                    : 675-8.","journal-title":"Am J Respir Crit Care Med."},{"key":"refR21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/thx.2011.160028","volume":"66","author":"Loke YK","year":"2011","unstructured":"Loke YK, Cavallazzi R, Singh S. \n                    Risk of fractures with inhaled corticosteroids in COPD Systematic review and meta-analysis of randomised controlled trials and observational studies. \n                    Thorax  \n                    2011; \n                    66\n                    : 699-708.","journal-title":"Thorax."},{"key":"refR22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0012-3692(15)31287-3","volume":"126","author":"Tashkin DP","year":"2004","unstructured":"Tashkin DP, Murray HE, Skeans M, Murray RP. \n                    Skin manifestations of inhaled corticosteroids in COPD patients Results from Lung Health Study, II. \n                     Chest  \n                    2004; \n                    126\n                    : 1123-33.","journal-title":"Chest."},{"key":"refR23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.280.6.539","volume":"280","author":"Garbe E","year":"1998","unstructured":"Garbe E, Suissa S, LeLorier J. \n                    Association of inhaled corticosteroid use with cataract extraction in elderly patients. \n                    JAMA  \n                    1998; \n                    280\n                    : 539-43.","journal-title":"JAMA."},{"key":"refR24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2010.06.019","volume":"123","author":"Suissa S","year":"2010","unstructured":"Suissa S, Kezouh A, Ernst P. \n                    Inhaled corticosteroids and the risks of diabetes onset and progression. \n                    Am J Med  \n                    2010; \n                    123\n                    : 1001-6.","journal-title":"Am J Med."},{"key":"refR25","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1016\/S0091-6749(98)70156-3","volume":"101","author":"Derendorf H","year":"1998","unstructured":"Derendorf H, Hochhaus G, Meibohm B, Mollmann H, Barth J. \n                    Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. \n                    J Allergy Clin Immunol  \n                    1998; \n                    101\n                    (4 Pt 2)\n                    : S440-6.","journal-title":"J Allergy Clin Immunol."},{"key":"refR26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0091-6749(03)80757-1","volume":"111","author":"Rohatagi S","year":"2003","unstructured":"Rohatagi S, Derandorf H, Zech K , et al. \n                    PK\/PD of inhaled corticosteroids The risk\/benefit of inhaled ciclesonide [abstract]. \n                    J Allergy Clin Immunol  \n                    2003; \n                    111\n                    (2)\n                    (SupplS218\n            )\n                    : 598.","journal-title":"J Allergy Clin Immunol."},{"key":"refR27","first-page":"91","author":"Hansel TT","year":"2001","unstructured":"Hansel TT, Barnes PJ, Dietzel K, Engelst\u00e4tter R, Keller A. \n                    Ciclesonide An on-site activated steroid New Drugs for asthma, allergy and COPD. \n                    Basle Karger  \n                    2001; \n                    91-3.","journal-title":"Basle Karger."},{"key":"refR28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2008.04.003","volume":"29","author":"Sturton G","year":"2008","unstructured":"Sturton G, Persson C, Barnes PJ. \n                    Small airways An important but neglected target in the treatment of obstructive airway diseases. \n                    Trends Phamacol Sci  \n                    2008; \n                    29\n                    : 340-5.","journal-title":"Trends Phamacol Sci."},{"key":"refR29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","volume":"172","author":"Usmani OS","year":"2005","unstructured":"Usmani OS, Biddiscombe MF, Barnes PJ. \n                    Regional lung deposition and bronchodilator response as a function of \u03ba2-agonist particle size. \n                    Am J Respir Crit Care Med  \n                    2005; \n                    172\n                    : 1497-504.","journal-title":"Am J Respir Crit Care Med."},{"key":"refR30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.rmed.2006.04.015","volume":"100","author":"Adamsa NP","year":"2006","unstructured":"Adamsa NP, Jonesb PW. \n                    The dose-response characteristics of inhaled corticosteroids when used to treat asthma An overview of Cochrane systematic reviews. \n                    Respir Med  \n                    2006; \n                    100\n                    : 1297-306.","journal-title":"Respir Med."},{"key":"refR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0091-6749(03)01870-0","volume":"112","author":"Kelly HW","year":"2003","unstructured":"Kelly HW, Nelson HS. \n                    Potential adverse effects of the inhaled corticosteroids. \n                    J Allergy Clin Immunol  \n                    2003; \n                    112\n                    : 469-78.","journal-title":"J Allergy Clin Immunol."},{"key":"refR32","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/08942680150506303","volume":"14","author":"Pritchard JN","year":"2001","unstructured":"Pritchard JN. \n                    The influence of lung deposition on clinical response. \n                    J Aerosol Med  \n                    2001; \n                    14\n                    (Suppl 1    )\n                    : S19-26.","journal-title":"J Aerosol Med."},{"key":"refR33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00074905","volume":"28","author":"Derendorf H","year":"2006","unstructured":"Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. \n                    Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. \n                    Eur Respir J  \n                    2006; \n                    28\n                    : 1042-50.","journal-title":"Eur Respir J."},{"key":"refR34","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1089\/08942680150506312","volume":"14","author":"Howarth PH","year":"2001","unstructured":"Howarth PH. \n                    Why particle size should affect clinical response to inhaled therapy. \n                    J Aerosol Med  \n                    2001; \n                    14\n                    (Suppl 1    )\n                    : S27-34.","journal-title":"J Aerosol Med."},{"key":"refR35","first-page":"S267","volume":"22","author":"Mutch E","year":"2003","unstructured":"Mutch E, Nave R, Zech K, Williams FM. \n                    Esterases involved in the hydrolysis of ciclesonide in human tissues. \n                    Eur Respir J  \n                    2003; \n                    22\n                    (Suppl 45\n    )\n                    : S267-8.","journal-title":"Eur Respir J."},{"key":"refR36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.mjt.0000155110.69831.75","volume":"12","author":"Rohatagi S","year":"2005","unstructured":"Rohatagi S, Luo Y, Shen L , et al. \n                    Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide. \n                    Am J Ther  \n                    2005; \n                    12\n                    : 201-9.","journal-title":"Am J Ther."},{"key":"refR37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0091270002250998","volume":"43","author":"Rohatagi S","year":"2003","unstructured":"Rohatagi S, Arya V, Zech K , et al. \n                    Population pharmacokinetics and pharmacodynamics of ciclesonide. \n                    J Clin Pharmacol  \n                    2003; \n                    43\n                    : 365-78.","journal-title":"J Clin Pharmacol."},{"key":"refR38","unstructured":"Schleimer RP, O'Bryne PM, Szefler SJ, Eds., et al. \n                    Systemic disposition and effects of inhaled corticosteroids Inhaled Steroids in Asthma. \n                    Optimizing effects in the airways New York Marcel Decker Inc.  \n                     2002; pp. \n                    3-33."},{"key":"refR39","first-page":"A773","volume":"167","author":"Miller-Larsson A","year":"2003","unstructured":"Miller-Larsson A, Axelsson B-O, Brattsand R, Edsbacker S, Ingelf J. \n                    Relative lipophilicity of budesonide, fluticasone propionate, mometasone furoate, and ciclesonide.Preference of variable lipophilicity in airways versus systemic compartment [Abstract]. \n                     Am J Respir Crit Care Med  \n                    2003; \n                    167\n                    : A773.","journal-title":"Am J Respir Crit Care Med."},{"key":"refR40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1164\/ajrccm.162.4.9806112","volume":"162","author":"Miller-Larsson A","year":"2000","unstructured":"Miller-Larsson A, Jansson P, Runstrom A, Brattsand R. \n                    Prolonged airway activity and improved selectivity of budesonide possibly due to esterification. \n                    Am J Respir Crit Care Med  \n                    2000; \n                    162\n                    : 1455-61.","journal-title":"Am J Respir Crit Care Med."},{"key":"refR41","first-page":"623","volume":"26","author":"Miller-Larsson A","year":"1998","unstructured":"Miller-Larsson A, Mattsson H, Hjertberg E, Dahlba\u00a8ck M, Tunek A, Brattsand R. \n                    Reversible fatty acid conjugation of budesonide.Novel mechanism for prolonged retention of topically applied steroid in airway tissue. \n                     Drug Metab Dispos  \n                    1998; \n                    26\n                    : 623-30.","journal-title":"Drug Metab Dispos."},{"key":"refR42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"Bousquet J","year":"2008","unstructured":"Bousquet J, Khaltaev N, Cruz AA , et al. \n                    Allergic rhinitis and its impact on asthma (ARIA) 2008, update (in collaboration with the World Health Organization, GA2- LEN and AllerGen). \n                    Allergy  \n                    2008; \n                    63\n                    : 8-160.","journal-title":"Allergy."},{"key":"refR43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.iac.2011.05.004","volume":"31","author":"Meltzer EO","year":"2011","unstructured":"Meltzer EO. \n                    The Role of Nasal Corticosteroids in the treatment of rhinitis. \n                    Immunol Allergy Clin N Am  \n                    2011; \n                    31\n                    : 545-60.","journal-title":"Immunol Allergy Clin N Am."},{"key":"refR44","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1398-9995.2008.01750.x","volume":"63","author":"Derendorf H","year":"2008","unstructured":"Derendorf H, Meltzer EO. \n                    Molecular and clinical pharmacology of intranasal corticosteroids Clinical and therapeutic implications. \n                    Allergy  \n                    2008; \n                    63\n                    : 1292-300.","journal-title":"Allergy."},{"key":"refR45","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"Rhen T","year":"2005","unstructured":"Rhen T, Cidlowski JA. \n                    Antiinflammatory action of glucocortic-oids-new mechanisms for old drugs. \n                    N Engl J Med  \n                    2005; \n                    353\n                    : 1711-23.","journal-title":"N Engl J Med."},{"key":"refR46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archotol.124.5.513","volume":"124","author":"Lund VJ","year":"1998","unstructured":"Lund VJ, Flood J, Sykes AP , et al. \n                    Effect of fluticasonein severe polyposis. \n                    Arch Otolaryngol Head Neck Surg  \n                    1998; \n                    124\n                    : 513-8.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"refR47","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2005.07.027","volume":"116","author":"Small CB","year":"2005","unstructured":"Small CB, Hernandez J, Reyes A , et al. \n                    Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. \n                    J Allergy Clin Immunol  \n                    2005; \n                    116\n                    : 1275-81.","journal-title":"J Allergy Clin Immunol."},{"key":"refR48","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1067\/mai.2001.115563","volume":"08","author":"Szefler SJ","year":"2001","unstructured":"Szefler SJ. \n                    Pharmacokinetics of intranasal corticosteroids. \n                    J Allergy Clin Immunol  \n                    2001; \n                    08\n                    (Suppl 1\n    )\n                    : S26-31.","journal-title":"J Allergy Clin Immunol."},{"key":"refR49","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1258\/002221503322542818","volume":"117","author":"Waddell AN","year":"2003","unstructured":"Waddell AN, Patel SK, Toma AG , et al. \n                    Intranasal steroid sprays in the treatment of rhinitis Is one better than another\u03ba. \n                    J Laryngol Otol  \n                    2003; \n                    117\n                    : 843-5.","journal-title":"J Laryngol Otol."},{"key":"refR50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.otohns.2008.05.628","volume":"139","author":"Joe S","year":"2008","unstructured":"Joe S, Thambi R, Huang J. \n                    A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. \n                    Otolaryngol Head Neck Surg  \n                    2008; \n                    139\n                    : 340-7.","journal-title":"Otolaryngol Head Neck Surg."},{"key":"refR51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","volume":"3","author":"Danielson PB","year":"2002","unstructured":"Danielson PB. \n                    The cytochrome P450 superfamily Biochemistry, evolution and drug metabolism in humans. \n                    Curr Drug Metab  \n                    2002; \n                    3\n                    : 561-97.","journal-title":"Curr Drug Metab."},{"key":"refR52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00228-009-0653-4","volume":"65","author":"Daveluy A","year":"2009","unstructured":"Daveluy A, Raignoux C, Miremont-Salam\u00e9 G. \n                    Drug interactions between inhaled corticosteroids and enzymatic inhibitors. \n                    Eur J Clin Pharmacol  \n                    2009; \n                    65\n                    : 743-5.","journal-title":"Eur J Clin Pharmacol."},{"key":"refR53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1569-1993(03)00022-5","volume":"2","author":"De Wachter E","year":"2003","unstructured":"De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J. \n                    Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. \n                    J Cyst Fibros  \n                    2003; \n                    2\n                    : 72-5.","journal-title":"J Cyst Fibros."},{"key":"refR54","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/02770903.2010.485666","volume":"47","author":"Kedem E","year":"2010","unstructured":"Kedem E, Shahar E, Hassoun G, Pollack S. \n                    Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. \n                    J Asthma  \n                    2010; \n                    47\n                    : 830-1.","journal-title":"J Asthma"},{"key":"refR55","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2005-0036","volume":"90","author":"Samaras K","year":"2005","unstructured":"Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. \n                    Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors Six cases. \n                    J Clin Endocrinol Metab  \n                    2005; \n                    90\n                    : 4394-8.","journal-title":"J Clin Endocrinol Metab"},{"key":"refR56","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"Newell-Price J","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB , et al. \n                    Cushing's syndrome. \n                    Lancet  \n                    2006; \n                    367\n                    (9522)\n                    : 1605-7.","journal-title":"Lancet."},{"key":"refR57","first-page":"137","volume":"50","author":"Cushing H","year":"1932","unstructured":"Cushing H. \n                    The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). \n                    Bull Johns Hopkins Hosp  \n                    1932; \n                    50\n                    : 137-95.","journal-title":"Bull Johns Hopkins Hosp."},{"key":"refR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314297","volume":"92","author":"Steffensen C","year":"2010","unstructured":"Steffensen C, Bak AM, Rubeck KZ, Jorgensen JO. \n                    Epidemiology of Cushing's syndrome. \n                    Neuroendocrinology  \n                    2010; \n                    92\n                    (Suppl 1\n    )\n                    : 1-5.","journal-title":"Neuroendocrinology."},{"key":"refR59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ecl.2005.01.013","volume":"34","author":"Hopkins RL","year":"2005","unstructured":"Hopkins RL, Leinung MC. \n                    Exogenous Cushing's syndrome and gluco\u00accorticoid withdrawal. \n                    Endocrinol Metab Clin North Am  \n                    2005; \n                    34\n                    : 371-84.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"refR60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0002-9343(61)90069-9","volume":"30","author":"Soffer LJ","year":"1961","unstructured":"Soffer LJ, Iannaccone A, Gabrilove JL. \n                    Cushing's syndrome A study of fifty patients. \n                    Am J Med  \n                    1961; \n                    30\n                    : 129.","journal-title":"Am J Med."},{"key":"refR61","first-page":"2791","volume":"80","author":"Wajchenberg BL","year":"1995","unstructured":"Wajchenberg BL, Bosco A, Marone MM , et al. \n                    Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. \n                    J Clin Endocrinol Metab  \n                    1995; \n                    80\n                    : 2791-4.","journal-title":"J Clin Endocrinol Metab."},{"key":"refR62","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/0303-7207(94)90113-9","volume":"102","author":"Mountjoy KG","year":"1994","unstructured":"Mountjoy KG. \n                    The human melanocyte stimulating hormone receptor has evolved to become super-sensitive to melanocortin peptides. \n                    Mol Cell Endocrinol  \n                    1994; \n                    102\n                    : R7-11.","journal-title":"Mol Cell Endocrinol."},{"key":"refR63","first-page":"3083","volume":"83","author":"Lado-Abeal J","year":"1998","unstructured":"Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD , et al. \n                    Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. \n                    J Clin Endocrinol Metab  \n                    1998; \n                    83\n                    : 3083-8.","journal-title":"J Clin Endocrinol Metab."},{"key":"refR64","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9343(66)90219-1","volume":"41","author":"Hutter AM","year":"1966","unstructured":"Hutter AM  Jr, Kayhoe DE. \n                    Adrenal cortical carcinoma Clinical features of 138 patients. \n                    Am J Med  \n                    1966; \n                    41\n                    : 572-80.","journal-title":"Am J Med."},{"key":"refR65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/qjmed\/89.7.543","volume":"89","author":"Kelly WF","year":"1996","unstructured":"Kelly WF. \n                    Psychiatric aspects of Cushing's syndrome. \n                    QJM  \n                    1996; \n                    89\n                    : 543-1.","journal-title":"QJM."},{"key":"refR66","first-page":"3515","volume":"84","author":"Ferrando AA","year":"1999","unstructured":"Ferrando AA, Stuart CA, Sheffield-Moore M, Wolfe RR. \n                    Inactivity amplifies the catabolic response of skeletal muscle to cortisol. \n                    J Clin Endocrinol Metab  \n                    1999; \n                    84\n                    : 3515-21.","journal-title":"J Clin Endocrinol Metab."},{"key":"refR67","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0889-8529(18)30090-2","volume":"23","author":"Adler RA","year":"1994","unstructured":"Adler RA, Rosen CJ. \n                    Glucocorticoids and osteoporosis. \n                    Endocrinol Metab Clin North Am  \n                    1994; \n                    23\n                    : 641-54.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"refR68","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(87)92870-4","volume":"1","author":"Felson DT","year":"1987","unstructured":"Felson DT, Anderson JJ. \n                    Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. \n                    Lancet  \n                    1987; \n                    1\n                    (8538)\n                    : 902-6.","journal-title":"Lancet."},{"key":"refR69","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","volume":"88","author":"Catargi B","year":"2003","unstructured":"Catargi B, Rigalleau V, Poussin A , et al. \n                    Occult Cushing's syndrome in type-2 diabetes. \n                    J Clin Endocrinol Metab  \n                    2003; \n                    88\n                    : 5808-13.","journal-title":"J Clin Endocrinol Metab."},{"key":"refR70","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-62-2-275","volume":"62","author":"Saruta T","year":"1986","unstructured":"Saruta T, Suzuki H, Handa M , et al. \n                    Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. \n                    J Clin Endocrinol Metab  \n                    1986; \n                    62\n                    : 275-9.","journal-title":"J Clin Endocrinol Metab."},{"key":"refR71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ecl.2011.01.006","volume":"40","author":"Sharma ST","year":"2011","unstructured":"Sharma ST, Nieman LK. \n                    Cushing's syndrome All variants, detection, and treatment. \n                    Endocrinol Metab Clin N Am  \n                    2011; \n                    40\n                    : 379-91.","journal-title":"Endocrinol Metab Clin N Am."},{"key":"refR72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","volume":"970","author":"Torpy DJ","year":"2002","unstructured":"Torpy DJ, Mullen N, Ilias I, Nieman LK. \n                    Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion A series of 58 cases. \n                    Ann N Y Acad Sci  \n                    2002; \n                    970\n                    : 134-44.","journal-title":"Ann N Y Acad Sci."},{"key":"refR73","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","volume":"61","author":"Mancini T","year":"2004","unstructured":"Mancini T, Kola B, Mantero F , et al. \n                    High cardiovascular risk in patients with Cushing's syndrome according to 1999, WHO\/ISH guidelines. \n                    Clin Endocrinol (Oxf)  \n                    2004; \n                    61\n                    : 768-7.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"refR74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000264775","volume":"7","author":"Sayegh F","year":"1975","unstructured":"Sayegh F, Weigelin E. \n                    Intraocular pressure in Cushing's syndrome. \n                    Ophthalmic Res  \n                    1975; \n                    7\n                    : 390-4.","journal-title":"Ophthalmic Res."},{"key":"refR75","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","volume":"2","author":"Ross EJ","year":"1982","unstructured":"Ross EJ, Linch DC. \n                    Cushing's syndrome-killing disease Discriminatory value of signs and symptoms aiding early diagnosis. \n                    Lancet  \n                    1982; \n                    2\n                    (8299)\n                    : 646-9.","journal-title":"Lancet."},{"key":"refR76","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/BF03349191","volume":"29","author":"Greening JE","year":"2006","unstructured":"Greening JE, Storr HL, McKenzie SA , et al. \n                    Linear growth and body mass index in pediatric patients with Cushing's disease or simple obesity. \n                    J Endocrinol Invest  \n                    2006; \n                    29\n                    : 885-7.","journal-title":"J Endocrinol Invest."},{"key":"refR77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199409083311002","volume":"331","author":"Magiakou MA","year":"1994","unstructured":"Magiakou MA, Mastorakos G, Oldfield EH , et al. \n                    Cushing's syndrome in children and adolescents.Presenttion diagnosis, and therapy. \n                    N Engl J Med  \n                    1994; \n                      331\n                    : 629-36.","journal-title":"N Engl J Med."},{"key":"refR78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.332.7539.469","volume":"332","author":"Woods DR","year":"2006","unstructured":"Woods DR, Arun CS, Corris PA, Perros P. \n                    Cushing's syndrome without excess cortisol. \n                    BMJ  \n                    2006; \n                    332\n                    (7539)\n                    : 469-70.","journal-title":"BMJ."},{"key":"refR79","unstructured":"Felig P, Frohman L, Chrousos GP, Eds. \n                    Glucocorticoid therapy Endocrinology and metabolism. \n                    4th ed New York McGraw-Hill.  \n                     2001; pp. \n                    609-32."},{"key":"refR80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1444-0938.2002.tb03011.x","volume":"85","author":"Jobling AI","year":"2002","unstructured":"Jobling AI, Augusteyn RC. \n                    What causes steroid cataracts\u03ba.A review of steroid-induced posterior subcapsular cataracts. \n                     Clin Exp Optom  \n                    2002; \n                    85\n                    : 61-75.","journal-title":"Clin Exp Optom."},{"key":"refR81","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJM199205283262206","volume":"326","author":"Mankin HJ","year":"1992","unstructured":"Mankin HJ. \n                    Nontraumatic necrosis of bone (osteonecrosis). \n                    N Engl J Med  \n                    1992; \n                    326\n                    : 1473-9.","journal-title":"N Engl J Med."},{"key":"refR82","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.39.8.1031","volume":"39","author":"Kaplan JG","year":"1989","unstructured":"Kaplan JG, Barasch E, Hirschfeld A , et al. \n                    Spinal epidural lipomatosis A serious complication of iatrogenic Cushing's syndrome. \n                    Neurology  \n                    1989; \n                    39\n                    : 1031-4.","journal-title":"Neurology."},{"key":"refR83","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa002304","volume":"345","author":"Israel E","year":"2001","unstructured":"Israel E, Banerjee TR, Fitzmaurice GM , et al. \n                    Effects of inhaled glucocorticoids on bone density in premenopausal women. \n                    N Engl J Med  \n                    2001; \n                    345\n                    : 941-7.","journal-title":"N Engl J Med."},{"key":"refR84","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","volume":"16","author":"van Staa T","year":"2001","unstructured":"van Staa T, Leufkens H, Cooper C. \n                    Use of inhaled corticosteroids and risk of fractures. \n                    J Bone Miner Res  \n                    2001; \n                    16\n                    : 581-8.","journal-title":"J Bone Miner Res."},{"key":"refR85","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(03)12811-5","volume":"361","author":"Agadi S","year":"2003","unstructured":"Agadi S. \n                    Iatrogenic Cushing's syndrome a different story. \n                    Lancet  \n                    2003; \n                    361\n                    (9362)\n                    : 1059.","journal-title":"Lancet."},{"key":"refR86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"Liu D","year":"2013","unstructured":"Liu D, Ahmet A, Ward L , et al. \n                    A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. \n                    Allergy Asthma Clin Immunol  \n                    2013; \n                    9\n                    : 30.","journal-title":"Allergy Asthma Clin Immunol."},{"key":"refR87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1545109709332019","volume":"8","author":"Valin N","year":"2009","unstructured":"Valin N, De Castro N, Garrait V , et al. \n                    Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone Description of 4 new cases and review of the literature. \n                    J Int Assoc Physicians AIDS Care (Chic)  \n                    2009; \n                    8\n                    : 113-21.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)."},{"key":"refR88","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/02770903.2010.485666","volume":"47","author":"Kedem E","year":"2010","unstructured":"Kedem E, Shahar E, Hassoun G , et al. \n                    Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. \n                    J Asthma  \n                    2010; \n                    47\n                    : 830-1.","journal-title":"J Asthma."},{"key":"refR89","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1086\/342562","volume":"35","author":"Gupta SK","year":"2002","unstructured":"Gupta SK, Dube MP. \n                    Exogenous Cushing's syndrome mimicking human immunodeficiency virus lipodystrophy. \n                    Clin Infect Dis  \n                    2002; \n                    35\n                    : E69-71.","journal-title":"Clin Infect Dis."},{"key":"refR90","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","volume":"30","author":"Carr A","year":"2000","unstructured":"Carr A. \n                    HIV protease inhibitor-related lipodystrophy syndrome. \n                    Clin Infect Dis  \n                    2000; \n                    30\n                    : S135-42.","journal-title":"Clin Infect Dis."},{"key":"refR91","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2265.2011.04096.x","volume":"75","author":"Tirabassi G","year":"2011","unstructured":"Tirabassi G, Papa R, Faloia E, Boscaro M, Arnaldi G. \n                    Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state A comparative study. \n                    Clin Endocrinol (Oxf)  \n                    2011; \n                    75\n                    : 666-72.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"refR92","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ecl.2005.02.001","volume":"34","author":"Findling JW","year":"2005","unstructured":"Findling JW, Raff H. \n                    Screening and diagnosis of Cushing's syndrome. \n                    Endocrinol Metab Clin North Am  \n                    2005; \n                    34\n                    : 385-402.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"refR93","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000216193","volume":"16","author":"Bruni FM","year":"2009","unstructured":"Bruni FM, De Luca G, Venturoli V, Boner AL. \n                    Intranasal corticosteroids and adrenal suppression. \n                    Neuroimmunomodulation  \n                    2009; \n                    16\n                    : 353-62.","journal-title":"Neuroimmunomodulation."},{"key":"refR94","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12020-010-9393-6","volume":"38","author":"Tempark T","year":"2010","unstructured":"Tempark T, Phatarakijnirund V, Chatproedprai S, Watcharasindhu S, Supornsilchai V, Wananukul S. \n                    Exogenous Cushing's syndrome due to topical corticosteroid application Case report and review literature. \n                    Endocrine  \n                    2010; \n                    38\n                    : 328-4.","journal-title":"Endocrine."},{"key":"refR95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/eje.0.1500687","volume":"150","author":"Kannisto S","year":"2004","unstructured":"Kannisto S, Laatikainen A, Taivainen A, Savolainen K, Tukiainen H, Voutilainen R. \n                    Serum dehydroepiandrosterone sulfate concentrations as an indicator adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. \n                    Eur J Endocrinol  \n                    2004; \n                    150\n                    : 687-90.","journal-title":"Eur J Endocrinol."},{"key":"refR96","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1468-1293.2008.00579.x","volume":"9","author":"Foisy MM","year":"2008","unstructured":"Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. \n                    Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone A review of the literature. \n                    HIV Med  \n                    2008; \n                    9\n                    : 389-96.","journal-title":"HIV Med."},{"key":"refR97","first-page":"180","volume":"5","author":"John G","year":"2013","unstructured":"John G, Ollo D, Meyer P , et al. \n                    Clinical course and management of iatrogenic Cushing's syndrome after co-administration of injected-triamcinolone and ritonavir A systematic review. \n                    J Antivir Antiretrovir  \n                    2013; \n                    5\n                    : 180-4.","journal-title":"J Antivir Antiretrovir."},{"key":"refR98","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.282.7.671","volume":"282","author":"Krasner AS","year":"1999","unstructured":"Krasner AS. \n                    Glucocorticoid-induced adrenal insufficiency. \n                    JAMA  \n                    1999; \n                    282\n                    : 671-.","journal-title":"JAMA."},{"key":"refR99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1081-1206(10)60400-0","volume":"100","author":"Wlodarczyk JH","year":"2008","unstructured":"Wlodarczyk JH, Gibson PG, Caeser M. \n                    Impact of inhaled corticosteroids on cortisol suppression in adults with asthma A quantitative review. \n                    Ann Allergy Asthma Immunol  \n                    2008; \n                    100\n                    : 23-30.","journal-title":"Ann Allergy Asthma Immunol."}],"container-title":["The Open Respiratory Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V8\/TORMJ-8-74\/TORMJ-8-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V8\/TORMJ-8-74\/TORMJ-8-74.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V8\/TORMJ-8-74\/TORMJ-8-74.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T05:33:37Z","timestamp":1561095217000},"score":1,"resource":{"primary":{"URL":"https:\/\/openrespiratorymedicinejournal.com\/VOLUME\/8\/PAGE\/74\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,31]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12,31]]}},"alternative-id":["TORMJ-8-74"],"URL":"https:\/\/doi.org\/10.2174\/1874306401408010074","relation":{},"ISSN":["1874-3064"],"issn-type":[{"value":"1874-3064","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2014-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}